Prentiss Smith & Co’s Merck MRK Stock Holding History

Prentiss Smith & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$373K	Sell	2,904 -70	-2%	-$8.19K	0.2%	57
2026 Q1	$358K	Sell	2,974 -16	-0.5%	-$1.85K	0.21%	57
2025 Q4	$315K	Hold	2,990	–	–	0.19%	58
2025 Q3	$251K	Hold	2,990	–	–	0.14%	67
2025 Q2	$237K	Sell	2,990 -100	-3%	-$7.95K	0.14%	66
2025 Q1	$277K	Hold	3,090	–	–	0.18%	64
2024 Q4	$307K	Hold	3,090	–	–	0.2%	61
2024 Q3	$351K	Sell	3,090 -450	-13%	-$53.5K	0.22%	58
2024 Q2	$438K	Hold	3,540	–	–	0.31%	49
2024 Q1	$467K	Sell	3,540 -199	-5%	-$24.5K	0.33%	47
2023 Q4	$408K	Hold	3,739	–	–	0.3%	50
2023 Q3	$385K	Sell	3,739 -328	-8%	-$35.4K	0.28%	49
2023 Q2	$469K	Hold	4,067	–	–	0.35%	44
2023 Q1	$433K	Hold	4,067	–	–	0.32%	47
2022 Q4	$451K	Hold	4,067	–	–	0.41%	40
2022 Q3	$350K	Hold	4,067	–	–	0.31%	50
2022 Q2	$371K	Hold	4,067	–	–	0.29%	54
2022 Q1	$334K	Hold	4,067	–	–	0.2%	62
2021 Q4	$312K	Sell	4,067 -80	-2%	-$6.37K	0.15%	70
2021 Q3	$311K	Hold	4,147	–	–	0.16%	68
2021 Q2	$323K	Sell	4,147 -199	-5%	-$14.8K	0.16%	67
2021 Q1	$320K	Sell	4,346 -918	-17%	-$67.7K	0.16%	64
2020 Q4	$411K	Sell	5,264 -815	-13%	-$62.3K	0.2%	57
2020 Q3	$481K	Buy	6,079 +152	+3%	+$11.9K	0.25%	51
2020 Q2	$437K	Hold	5,927	–	–	0.27%	47
2020 Q1	$435K	Buy	5,927 +461	+8%	+$36.2K	0.3%	44
2019 Q4	$474K	Hold	5,466	–	–	0.3%	46
2019 Q3	$439K	Hold	5,466	–	–	0.29%	46
2019 Q2	$437K	Buy	5,466 +265	+5%	+$20.3K	0.29%	47
2019 Q1	$413K	Buy	5,201 +262	+5%	+$19.6K	0.26%	48
2018 Q4	$360K	Sell	4,939 -84	-2%	-$5.93K	0.23%	51
2018 Q3	$340K	Buy	5,023 +734	+17%	+$46.8K	0.19%	51
2018 Q2	$248K	Sell	4,289 -1,635	-28%	-$92.2K	0.15%	57
2018 Q1	$308K	Buy	5,924 +128	+2%	+$6.91K	0.16%	65
2017 Q4	$311K	Hold	5,796	–	–	0.15%	66
2017 Q3	$354K	Hold	5,796	–	–	0.2%	55
2017 Q2	$354K	Buy	5,796 +733	+14%	+$44.6K	0.19%	56
2017 Q1	$307K	Sell	5,063 -132	-3%	-$8.01K	0.17%	59
2016 Q4	$292K	Hold	5,195	–	–	0.18%	55
2016 Q3	$309K	Sell	5,195 -1,004	-16%	-$58.7K	0.17%	60
2016 Q2	$341K	Sell	6,199 -90	-1%	-$4.79K	0.19%	58
2016 Q1	$318K	Hold	6,289	–	–	0.18%	59
2015 Q4	$317K	Buy	6,289 +734	+13%	+$37K	0.17%	59
2015 Q3	$262K	Sell	5,555 -734	-12%	-$39K	0.15%	62
2015 Q2	$342K	Sell	6,289 -139	-2%	-$7.8K	0.17%	59
2015 Q1	$353K	Buy	6,428 +733	+13%	+$41.5K	0.17%	60
2014 Q4	$309K	Buy	5,695 +151	+3%	+$8.41K	0.14%	62
2014 Q3	$314K	Hold	5,544	–	–	0.16%	60
2014 Q2	$306K	Hold	5,544	–	–	0.16%	59
2014 Q1	$300K	Buy	5,544 +289	+5%	+$15K	0.16%	60
2013 Q4	$251K	Sell	5,255 -80	-1%	-$3.66K	0.13%	59
2013 Q3	$242K	Hold	5,335	–	–	0.13%	59
2013 Q2	$236K	Buy	+5,335	New	+$238K	0.12%	65

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Prentiss Smith & Co's MRK Position: Q2 2026 in Review

Prentiss Smith & Co reduced its Merck (MRK) stake by 2.4% in Q2 2026, selling an estimated $8.19K and leaving 2,904 shares worth $373K. The position accounts for 0.2% of the portfolio, ranked #57.

Prentiss Smith & Co first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $481K in Q3 2020. 1,713 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Prentiss Smith & Co held 2,904 shares of Merck worth $373K as of Q2 2026.
Prentiss Smith & Co sold 70 Merck shares in Q2 2026, an estimated $8.19K.
Merck made up 0.2% of Prentiss Smith & Co's portfolio in Q2 2026, its #57 holding.
Prentiss Smith & Co first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
Prentiss Smith & Co's Merck position peaked at $481K in Q3 2020.
1,713 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Prentiss Smith & Co's 13F filing for Q2 2026, filed 30 Jul 2026.